Simon C. Lowry's most recent trade in Emergent Biosolutions Inc was a trade of 62,500 Employee Stock Options (Right to Buy) done . Disclosure was reported to the exchange on March 6, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Emergent Biosolutions Inc | Simon C. Lowry | SVP, R&D, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 62,500 | 102,999 | - | - | Employee Stock Options (Right to Buy) | |
Emergent Biosolutions Inc | Simon C. Lowry | SVP, R&D, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 62,500 | 91,982 (0%) | 0% | 0 | Common Stock | |
Emergent Biosolutions Inc | Simon C. Lowry | SVP, R&D, CMO | 15 Dec 2024 | 40,499 | 40,499 | - | - | Employee Stock Option (Right to buy) | ||
Emergent Biosolutions Inc | Simon C. Lowry | SVP, R&D, CMO | 15 Dec 2024 | 29,482 | 29,482 (0%) | 0% | 0 | Common Stock |